#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
Hyperbilirubinemia is a condition in which there is too much bilirubin in your baby’s blood.
When red blood cells break down, a substance called bilirubin is formed. Babies are not easily able to get rid of the bilirubin, and it can build up in the blood and other tissues and fluids of your baby’s body. This is called hyperbilirubinemia. Because bilirubin has a pigment or coloring, it causes a yellowing of your baby’s skin and tissues. This is called jaundice.
Depending on the cause of the hyperbilirubinemia, jaundice may appear at birth or at any time afterward.
How Children’s approaches hyperbilirubinemia
Children and adolescents with all forms of non-malignant blood disorders, including anemias, bleeding problems, blood clots, platelet disorders and red and white blood cell disorders, are treated through our Pediatric Hematology service. If necessary, Children’s also offers access to the largest pediatric stem cell transplantation program in New England.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”